Computed Tomography Market Set to Witness an Uptick during 2019 to 2026
The global computed
tomography market size is expected
to reach USD 9.1 billion by 2026,
according to a new report by Grand View Research, Inc., exhibiting a CAGR of 6.5%. Increasing burden of
chronic disorders, such as cardiovascular diseases and cancer, and high demand
for effective imaging tools are the factors driving growth. In addition,
increasing demand for computed tomography (CT) systems in emergency care
departments is expected to be a major driver during the forecast period.
The longer incubation period of SARS-CoV is a
huge restriction for early diagnosis and effective treatment for the ongoing
pandemic. Preliminary screening of suspected patients by CT can reveal lung
damages at the early stages. This has a significant impact in the developing
countries where tests/million population ratio is lower. Recent trends of
makeshift hospitals and temporary screening centers are expected to fuel the
demand for portable and mobile CT scanners. We are working to account for this
surge in our estimates. The updated report will account for Covid-19 as a key
market contributor.
Advanced technology with features such
as dose management systems, ability to diagnose tumors through motion (4D), and
high-end material differentiation is expected to replace the existing
conventional devices. Increasing number of favorable reimbursement policies by
government as well as private entities are also expected to drive the CT market
at a lucrative pace.
Establishment new screening guidelines
in 2011 by NCCN Lung Cancer Screening Panel is expected to have a positive
impact on market growth. CT scan is considered as an effective imaging tool and
it is required through the lung cancer detection and treatment process to the
comparative study of images to monitor the effectiveness of medication
prescribed.
The leading
players in computed tomography market include Canon Medical Systems
Corporation, FUJIFILM Corporation, General Electric Company, Hitachi, Ltd.,
Koning Corporation, Koninklijke Philips NV, NeuroLogica Corp, Neusoft
Corporation, Siemens Healthcare GmbH, Shenzhen Anke High-Tech Co. These players
are focusing on growth strategies, such as product launches, innovations in the
existing product, and mergers & acquisitions. For instance, In March 2019,
Siemens Healthineers received USFDA approval for the launch of their product
called SOMATOM Force, that has dual source and dual detectors technology coupled with 4D imaging with minimum radiation
exposure.
To Request Sample Copy of this report, click the link:
Growing demand for ambulatory
diagnostic centers due to improving affordability and increasing reach of CT
scanners to remote regions is expected to aid further growth. Moreover, the
inability of alternative imaging technologies to provide quick reports and at
the same time be cost-effective boosts growth. These devices and this
technology is also routinely upgraded, which is expected to further increase
demand over the forecast period.
Further key findings from the report
suggest:
·
High end and mid end slice CT
segments held a significant share in of the computed tomography market. The
increasing demand for advance technology with enhanced imaging quality and the
shifting focus on providing quality healthcare services has contributed to this
growth.
·
Based on end use, hospital
captured largest revenue share in 2018. Large patient pool and high demand for
CT scanners as a diagnostic tool during treatment are expected to contribute
toward the growth of this segment.
·
North America dominated the CT
market in 2019. High adoption of advanced technology and presence of a large
number of market players are some of the factors that can be attributed to this
share.
·
Asia Pacific is expected to
grow at the fastest rate over the forecast period. Growing demand for advanced imaging
techniques and rising number of diagnostic imaging centers are some of the
factors driving regional growth.
·
Major players in the industry
are focusing on launch of advanced technology and features such as artificial
intelligence enabled, dual source detector technology based CT scanners.
The
global computed tomography (CT) market size was valued at USD 5.53 million in
2018 and is projected to expand at a CAGR of 6.5% by 2026. Growing prevalence
of various lifestyle associated chronic diseases such as cancer and
cardiovascular conditions and increasing demand for advanced imaging solutions
are some of the factors expected to drive the overall market growth.
CT
scans are critical diagnostics tool especially for lung cancer and traumatic
brain injuries. CDC reported that in 2013, more than 2.8 million people visited
emergency department in U.S. for traumatic brain injuries. CT scans are the
only option to assess the condition during emergency brain trauma. Increasing
demand for advanced assessment tools in emergency department, and growing
number of ambulatory emergency care units are the factors expected to have
positive impact on the CT market growth.
According
to NCBI, more than 70 million CT scans are performed in U.S. and 5 million in
U.K every year with an annual increasing rate of 10%, signifying the growth
potential of CT in overall medical imaging market. Steep rise in the
applications of CT scans and growing trends of using CT scans for effective
lung cancer screening are expected to boost the demand for CT scanners in
developed as well as developing countries. Growing applications of CT also
extend in dentistry to detect teeth decay and to assess infection in
surrounding areas.
Introduction
of technologically advanced devices, and development of accessories to enhance
image quality obtained by conventional CT scanners are the major factors
expected to fuel the market growth. Introduction of advanced cone beam computed
tomography (CBCT) systems is expected to be the major factor widening the applications
of CT in modern diagnostic imaging. Dual source and artificial intelligence
enabled CT scanners are expected to be important milestones in the market
growth. ClariPi Inc received FDA clearance for its artificial intelligence
enabled CT scanner called “ClariCT.AI” in June 2019.
Browse Press
Release of this report:
Grand View Research has segmented the
computed tomography market on the basis of technology, application, end use:
Computed Tomography Technology Outlook (Volume in ‘000 Units; Revenue, USD Million,
2015 - 2026)
·
High end slice
·
Mid end slice
·
Low end slice
·
Cone beam
Computed Tomography Application Outlook (Revenue, USD Million, 2015 - 2026)
·
Oncology
·
Neurology
·
Cardiology
·
Vascular
·
Musculoskeletal
·
Others
Computed Tomography End-use Outlook (Revenue, USD Million, 2015 - 2026)
·
Hospitals
·
Diagnostics imaging center
·
Ambulatory imaging center
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.

Comments
Post a Comment